Homepage
Healthcare · Medical - Devices · United States · Updated May 11, 1:54pm
$5.38
Price
$292.9M
Market Cap
216
Employees
2.38
Beta
Paul Badawi
CEO
Business Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Business History
Price Overview
Last updated: May 11, 2026 1:54pm (just now)$5.38
+0.00 (+0.05%)
Day Range
$5.25 – $5.53
52-Week Range
$3.06 – $9.24
50-Day MA
$4.07
200-Day MA
$5.14
Volume
116,574.78
Analyst Price Targets
Low
$8.00
Consensus
$9.67
High
$12.00
(15 analysts)
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-7.27
Stock Price: $5.38
EPS (Diluted): -0.74
EPS (Diluted): -0.74
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
6.47
Stock Price: $5.38
Total Equity: $63.94M
Shares: 52,148,543
Total Equity: $63.94M
Shares: 52,148,543
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-6.85
Market Cap: $292.87M
Total Debt: $40.30M
Cash: $91.97M
EBITDA: -$36.61M
Total Debt: $40.30M
Cash: $91.97M
EBITDA: -$36.61M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$248.8M
Market Cap: $292.87M
Total Debt: $40.30M
Cash: $91.97M
Total Debt: $40.30M
Cash: $91.97M
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
86.2%
Gross Profit: $66.67M
Revenue: $77.36M
Revenue: $77.36M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-48.0%
Operating Income: -$37.10M
Revenue: $77.36M
Revenue: $77.36M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-49.7%
Net Income: -$38.43M
Revenue: $77.36M
Revenue: $77.36M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-59.1%
Net Income: -$38.43M
Total Equity: $63.94M
Total Equity: $63.94M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-37.2%
Operating Income: -$37.10M
Tax Rate: 0.0%
Equity: $63.94M
Total Debt: $40.30M
Cash: $91.97M
Tax Rate: 0.0%
Equity: $63.94M
Total Debt: $40.30M
Cash: $91.97M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
5.86
Current Assets: $112.73M
Current Liabilities: $11.03M
Current Liabilities: $11.03M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.63
Short-Term Debt: $0.00
Long-Term Debt: $40.30M
Total Debt: $40.30M
Total Equity: $63.94M
Long-Term Debt: $40.30M
Total Debt: $40.30M
Total Equity: $63.94M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$1.48
Revenue: $77.36M
Shares: 52,148,543
Shares: 52,148,543
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$1.23
Total Equity: $63.94M
Shares: 52,148,543
Shares: 52,148,543
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.57
Operating CF: -$29.69M
CapEx: -$224,000
Shares: 52,148,543
CapEx: -$224,000
Shares: 52,148,543
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $5.38
Stock Price: $5.38
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$38.43M
Net Income: -$38.43M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares SGHT against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $49.0M | $71.3M | $81.1M | $79.9M | $77.4M |
| Cost of Revenue | $8.6M | $12.4M | $11.9M | $11.6M | $10.7M |
| Gross Profit | $40.3M | $59.0M | $69.2M | $68.3M | $66.7M |
| Operating Expenses | $91.8M | $142.9M | $126.4M | $118.8M | $103.8M |
| Operating Income | -$51.5M | -$84.0M | -$57.3M | -$50.5M | -$37.1M |
| Net Income | -$63.0M | -$86.2M | -$55.5M | -$51.5M | -$38.4M |
| EBITDA | -$57.2M | -$80.5M | -$49.4M | -$45.9M | -$36.6M |
| EPS | $-1.33 | $-1.80 | $-1.14 | $-1.03 | $-0.74 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $260.7M | $185.0M | $138.1M | $120.4M | $92.0M |
| Total Current Assets | $277.0M | $209.7M | $162.9M | $139.8M | $112.7M |
| Total Assets | $280.2M | $213.1M | $166.7M | $142.8M | $115.3M |
| Current Liabilities | $13.5M | $17.8M | $12.3M | $15.5M | $11.0M |
| Long-Term Debt | $32.7M | $33.3M | $31.7M | $39.4M | $40.3M |
| Total Liabilities | $48.1M | $53.0M | $46.4M | $55.3M | $51.4M |
| Total Equity | $232.1M | $160.1M | $120.2M | $87.5M | $63.9M |
| Retained Earnings | -$153.0M | -$239.2M | -$294.8M | -$346.3M | -$384.7M |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$52.5M | -$76.0M | -$47.2M | -$22.4M | -$29.7M |
| Capital Expenditure | $-813,000 | $-970,000 | $-791,000 | $-385,000 | $-224,000 |
| Free Cash Flow | -$53.4M | -$76.9M | -$48.0M | -$22.7M | -$29.9M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $199.2M | -$75.7M | -$46.9M | -$17.8M | -$28.1M |
Analyst Estimates (Annual)
| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$77.3M $77.3M – $77.3M
|
$86.0M $85.5M – $86.8M
|
$95.7M $94.2M – $97.8M
|
$103.7M $102.7M – $104.8M
|
| EBITDA |
$10.7M $10.7M – $10.8M
|
$12.0M $11.9M – $12.1M
|
$13.3M $13.1M – $13.6M
|
$14.4M $14.3M – $14.6M
|
| Net Income |
-$37.3M -$42.0M – -$35.0M
|
-$42.4M -$51.7M – -$31.3M
|
-$32.0M -$37.0M – -$15.1M
|
-$22.0M -$32.5M – -$15.2M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +45.7% | +13.6% | -1.5% | -3.1% |
| Gross Profit Growth | +46.2% | +17.3% | -1.3% | -2.4% |
| Operating Income Growth | -63.1% | +31.8% | +11.8% | +26.6% |
| Net Income Growth | -37.0% | +35.6% | +7.3% | +25.4% |
| EBITDA Growth | -40.7% | +38.6% | +7.1% | +20.2% |
No community reviews yet for SGHT.
Be the first — export the analysis to your AI and contribute back.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27